A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
2004 · British Journal of Cancer · 173 citations
https://doi.org/10.1038/sj.bjc.6601617
AZ Sint-Jan(BE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
688
Citations
9
h-index
9
i10-index
Ivar Bleumer is an academic researcher from AZ Sint-Jan. The author has contributed to research in topics: Renal cell carcinoma treatment & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 9, co-authored 20 publications.
https://doi.org/10.1038/sj.bjc.6601617
https://doi.org/10.1016/j.cont.2025.102295
Click to start Chat